SLC1A5 and hepatocellular carcinoma: It was also observed that BBR reduced the expression levels of glucose–alanine cycle related proteins ASCT2 and GLUT1, while this effect was reversed in BBR-treated HCC cells with GPT1 overexpression under alanine-rich conditions (Figure 6D and Figure S10).